Article Information
History
- February 6, 2023.
Article Versions
- Version 1 (February 2, 2023 - 21:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ann M. Iverson1,
- Amanda L. Arbuckle2,
- Keisuke Ueda, M.D.3,
- David Y. Song4,
- Emily C. Bihun, M.Ed.2,
- Jonathan M. Koller, BSEE, BSBME2,
- Michael Wallendorf, Ph.D.5 and
- Kevin J. Black, M.D.6,*
- 1Washington University in St. Louis School of Medicine, St. Louis, MO
- 2Department of Psychiatry, Washington University in St. Louis
- 3Department of Neurology, Washington University in St. Louis
- 4University of Rochester School of Medicine and Dentistry, Rochester, NY
- 5Division of Biostatistics, Washington University in St. Louis
- 6Departments of Psychiatry, Neurology, Radiology, and Neuroscience, Washington University in St. Louis, St. Louis, MO
- ↵*Address questions to Dr. Black at kevin{at}WUSTL.edu or MSC 8134-70-2205, 660 S. Euclid Avenue, St. Louis, Missouri 63110-1010
Posted February 06, 2023.
Peripheral nerve induction of inhibitory brain circuits to treat Tourette syndrome: A randomized crossover trial
